Commentary - (2025) Volume 16, Issue 2
Received: 01-Apr-2025, Manuscript No. jfr-26-184091;
Editor assigned: 03-Apr-2025, Pre QC No. P-184091;
Reviewed: 17-Apr-2025, QC No. Q-184091;
Revised: 22-Apr-2025, Manuscript No. R-184091;
Published:
29-Apr-2025
, DOI: 10.37421/2157-7145.2025.16.652
Citation: Chatterjee, Ananya. ”Forensic Toxicology: Battling Evolving Novel Psychoactive Substances.” J Forensic Res 16 (2025):652.
Copyright: © 2025 Chatterjee A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and source are credited.
Forensic toxicology faces persistent challenges due to the continuous emergence of novel psychoactive substances (NPS). These substances, often synthesized to evade existing legal frameworks, present considerable analytical obstacles for laboratories [1].
The landscape of synthetic cannabinoids serves as a prominent illustration of these evolving drug challenges. These compounds, frequently marketed as 'legal highs,' exhibit a broad spectrum of pharmacological effects and significant structural diversity, necessitating sophisticated analytical approaches for their identification [2].
Designer benzodiazepines represent another considerable threat, characterized by their widespread availability and potent anxiolytic and sedative properties. Their detection and quantification in biological matrices, particularly in forensic investigations, demand highly sensitive and specific analytical methods [3].
The escalating prevalence of synthetic opioids, which differ from classical opioids like morphine and codeine, constitutes a critical public health emergency. Analytical strategies for identifying these novel synthetic opioids in biological fluids and seized materials are vital for law enforcement and clinical interventions [4].
New psychoactive cathinones (NPSCs) continue to appear, posing complex analytical difficulties for forensic laboratories. Developing comprehensive methods for their detection, especially in matrices like hair for retrospective assessment, is crucial [5].
The increasing occurrence of 'research chemicals' containing unknown or novel substances mandates the development of adaptable analytical workflows in forensic toxicology. This requires advanced techniques capable of untargeted screening of complex biological matrices [6].
The development and validation of robust analytical methods are fundamental for the reliable detection of emerging drugs of abuse. Methods for the simultaneous determination of designer stimulants, including novel synthetic cathinones and phenethylamines, in biological samples are essential for routine forensic screening [7].
The identification of novel hallucinogens, particularly those derived from tryptamine or phenethylamine structures, presents a significant hurdle in forensic casework. Rapid screening techniques are necessary to address this challenge [8].
The emergence of novel psychoactive substances (NPS) often involves subtle structural modifications to existing drug classes, complicating their detection. Techniques that can provide additional separation dimensions are crucial for differentiating structurally similar compounds [9].
The global threat posed by emerging synthetic drugs necessitates international cooperation and enhanced analytical capabilities. Robust identification and characterization strategies are vital for forensic laboratories to effectively address the continuous evolution of NPS [10].
Forensic toxicology is continuously confronted by the emergence of novel psychoactive substances (NPS), which often possess structures designed to circumvent legal controls, thereby creating significant analytical challenges [1].
The realm of synthetic cannabinoids exemplifies the evolving nature of drug threats. These compounds, frequently disguised as 'legal highs,' display diverse pharmacological effects and structural variations, demanding advanced chromatographic and mass spectrometric techniques for their identification and quantification in biological samples [2].
Designer benzodiazepines constitute a substantial risk due to their pervasive availability and potent effects. Research efforts are focused on developing sophisticated Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) methods for their simultaneous detection and quantification, particularly in post-mortem specimens, to aid in determining causes of death [3].
The growing crisis of synthetic opioids, distinct from traditional opioids, necessitates robust analytical strategies for their identification in biological fluids and seized materials. This involves employing rapid and sensitive techniques to support law enforcement and manage overdose cases [4].
New psychoactive cathinones (NPSCs) continue to emerge, presenting complex detection challenges. The development of comprehensive Gas Chromatography-Tandem Mass Spectrometry (GC-MS/MS) methods for the analysis of NPSCs and their metabolites in biological matrices like hair is essential for assessing chronic use patterns [5].
The increasing prevalence of 'research chemicals' containing unknown or novel substances requires flexible analytical workflows. Techniques such as comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GCxGC-TOFMS) are being evaluated for their ability to perform untargeted screening of complex samples [6].
The reliable detection of emerging drugs of abuse hinges on the development of validated analytical methods. For instance, a validated LC-MS/MS method for the simultaneous determination of designer stimulants in urine is crucial for routine forensic toxicology screening and for adapting to new drug trends [7].
Identifying novel hallucinogens, especially those with tryptamine or phenethylamine structures, poses a considerable challenge in forensic casework. Rapid screening using techniques like direct infusion high-resolution mass spectrometry (DI-HRMS) can aid in the elemental composition determination and identification of previously uncharacterized substances [8].
The complexity introduced by structural modifications in emerging drugs necessitates enhanced analytical techniques. Ion mobility-mass spectrometry (IM-MS) offers an additional separation dimension that can assist in differentiating isomeric and isobaric compounds commonly found in emerging drugs [9].
The global threat posed by emerging synthetic drugs demands strong international collaboration and advanced analytical capabilities. Forensic laboratories must develop rapid methods, share data, and utilize sophisticated instrumentation to identify and characterize new psychoactive substances effectively [10].
Forensic toxicology is grappling with the continuous emergence of novel psychoactive substances (NPS) that pose significant analytical challenges. This includes the analysis of synthetic cannabinoids, designer benzodiazepines, synthetic opioids, new psychoactive cathinones, and novel hallucinogens. Advanced analytical techniques such as GC-MS/MS, LC-MS/MS, and high-resolution mass spectrometry are crucial for their identification and quantification in various biological and seized samples. The development of validated methods, untargeted screening, and complementary separation techniques like ion mobility-mass spectrometry are essential for addressing these evolving drug trends. International collaboration and the continuous evolution of analytical strategies are vital for effective forensic analysis and public safety.
Journal of Forensic Research received 2328 citations as per Google Scholar report
